Natera, Inc. (NTRA)

Regulus Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	973.77	945.59	642.1	466.09	84.39	48.67
Short-Term Investments	17.83	22.69	236.88	432.3	829.9	688.61
Cash & Short-Term Investments	991.6	968.28	878.98	898.39	914.28	737.27
Cash Growth	12.31%	10.16%	-2.16%	-1.74%	24.01%	67.19%
Receivables	318.23	314.17	278.29	244.39	122.07	78.57
Inventory	50.37	44.74	40.76	35.41	26.91	20.03
Prepaid Expenses	56.19	47.84	60.52	33.63	29.65	26.61
Restricted Cash	-	-	-	-	0.23	0.19
Other Current Assets	-	0.8	-	-	-	-
Total Current Assets	1,416	1,376	1,259	1,212	1,093	862.66
Property, Plant & Equipment	275.08	248.2	167.75	164.33	122.23	53.05
Other Intangible Assets	-	-	-	-	2.3	1.7
Long-Term Deferred Charges	-	-	-	0	-	-
Other Long-Term Assets	40.9	36.72	15.4	18.33	18.82	14.74
Total Assets	1,732	1,661	1,442	1,394	1,236	932.15
Accounts Payable	49.99	42.82	26.23	44.43	31.01	10.82
Accrued Expenses	182.89	172.57	144.85	146.54	105.68	61.7
Short-Term Debt	80.35	80.36	80.4	80.35	50.05	50.05
Current Portion of Leases	12.2	10.17	11.62	7.64	5.75	7.3
Current Unearned Revenue	20.56	19.75	16.61	10.78	7.4	50.13
Other Current Liabilities	19.7	18.37	27.56	20.77	19.06	19.06
Total Current Liabilities	365.68	344.05	307.27	310.5	218.96	199.05
Long-Term Debt	-	-	282.95	281.65	280.39	202.49
Long-Term Leases	103.06	96.59	67.03	76.58	61.04	21.25
Long-Term Unearned Revenue	23.96	24.68	19.13	20	21.32	22.81
Other Long-Term Liabilities	-	-	-	-	1.48	0.32
Total Liabilities	492.69	465.32	676.37	688.73	583.18	445.92
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	3,875	3,764	3,146	2,665	2,050	1,411
Retained Earnings	-2,635	-2,568	-2,377	-1,943	-1,395	-929.32
Comprehensive Income & Other	-0.2	-0.34	-3.09	-16.36	-2.29	4.26
Total Common Equity	1,240	1,195	765.33	705.74	653.3	486.24
Shareholders' Equity	1,240	1,195	765.33	705.74	653.3	486.24
Total Liabilities & Equity	1,732	1,661	1,442	1,394	1,236	932.15
Total Debt	195.6	187.12	441.99	446.22	397.23	281.09
Net Cash (Debt)	796	781.16	436.98	452.17	517.05	456.18
Net Cash Growth	79.62%	78.76%	-3.36%	-12.55%	13.34%	59.97%
Net Cash Per Share	6.21	6.26	3.80	4.59	5.71	5.63
Filing Date Shares Outstanding	136.55	135.19	120.76	113.29	95.47	86.57
Total Common Shares Outstanding	135.93	132.65	119.58	111.26	95.14	86.22
Working Capital	1,051	1,032	951.28	901.32	874.18	663.61
Book Value Per Share	9.12	9.01	6.40	6.34	6.87	5.64
Tangible Book Value	1,240	1,195	765.33	705.74	651	484.54
Tangible Book Value Per Share	9.12	9.01	6.40	6.34	6.84	5.62
Machinery	132.29	120.25	87.48	67.57	38.62	54.81
Construction In Progress	71.27	58.46	29.39	25.37	30.28	6.37
Leasehold Improvements	48.88	48.57	39	29.75	13.64	14.81

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q